Literature DB >> 913436

Prognosis of Wilson's disease in childhood.

M Arima, K Takeshita, K Yoshino, T Kitahara, Y Suzuki.   

Abstract

Wilson's disease in childhood has several characters distinct from those in adults. The progression of the disease tends to be rapid, hepatic manifestations are common, cerebral symptoms related to dystonia are predominant, and tremor is rare. Forty-nine children with Wilson's disease under the age of 15 were treated with D-penicillamine for 2 to 15 years. None of the presymptomatic patients subsequently developed any symptoms of the disease. The results of treatment in patients who had exhibited only hepatic symptoms were also excellent. However, neurological manifestations associated with a history of jaundice or ascites responded less well to chelation. These observations clearly indicate that early diagnosis and treatment are extremely important to ensure normal lives for children with Wilson's disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913436     DOI: 10.1007/bf00442196

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE). TWO DIFFERENT COMPONENTS.

Authors:  D DENNY-BROWN
Journal:  N Engl J Med       Date:  1964-05-28       Impact factor: 91.245

2.  The liver in juvenile Wilson's disease.

Authors:  M SILVERBERG; S S GELLIS
Journal:  Pediatrics       Date:  1962-09       Impact factor: 7.124

3.  The diagnosis of Wilson's disease in asymptomatic patients.

Authors:  I STERNLIEB; I H SCHEINBERG
Journal:  JAMA       Date:  1963-03-02       Impact factor: 56.272

4.  Prevention of Wilson's disease in asymptomatic patients.

Authors:  I Sternlieb; I H Scheinberg
Journal:  N Engl J Med       Date:  1968-02-15       Impact factor: 91.245

5.  Prevention of Wilson's disease in asymptomatic patients.

Authors:  M Arima; K Komiya; A Fujisawa; K Matsuoka
Journal:  Proc Aust Assoc Neurol       Date:  1968

Review 6.  The physiology of copper in man and its relation to Wilson's disease.

Authors:  J M Walshe
Journal:  Brain       Date:  1967-03       Impact factor: 13.501

7.  Prevention of Wilson's disease--a long term follow-up.

Authors:  M Arima; K Komiya
Journal:  Paediatr Univ Tokyo       Date:  1970-12

8.  Long-term therapy of Wilson's disease.

Authors:  A Deiss; R E Lynch; G R Lee; G E Cartwright
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

9.  A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration).

Authors:  A G BEARN
Journal:  Ann Hum Genet       Date:  1960-04       Impact factor: 1.670

10.  CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN WILSON'S DISEASE IN CASES UNDER TEN YEARS OF AGE.

Authors:  M ARIMA; K KOMIYA; S KAMOSHITA; N MUKAI
Journal:  Paediatr Univ Tokyo       Date:  1963-12
View more
  3 in total

1.  Effective D-penicillamine treatment of an early diagnosed patient with Wilson's disease.

Authors:  J P van Wouwe; M H van Weel-Sipman; M A Giesberts; D J Ruiter; H H van Gelderen
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

2.  Don't forget Wilson's disease.

Authors: 
Journal:  Br Med J       Date:  1978-11-18

3.  Wilson's disease: assessment of D-penicillamine treatment.

Authors:  M Van Caillie-Bertrand; H J Degenhart; I Luijendijk; J Bouquet; M Sinaasappel
Journal:  Arch Dis Child       Date:  1985-07       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.